Payment overview · 2025
General Payments
$506.16
30 reported records · 8 companies
Healthcare provider profile · identity verified
Adolphus Ray Lewis, DO
Allopathic & Osteopathic Physicians|Family Medicine · FORT WORTH, TX · NPI 1265403497
Verified facts
What the public records show
CMS Open Payments records show Adolphus Ray Lewis, DO received $506.16 in general payments during 2025 across 30 reported records.
Aucta Pharmaceuticals, Inc. accounted for 32.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 8 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ingrezza.
E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 734 claims for Eliquis by this doctor in 2024.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 112 claims for Ingrezza by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 40 claims for Nuedexta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Aucta Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $164.48 | 32.5% | 16 | 2025 |
| Alpha Cognition USA, Inc. | Unresolved — no canonical attribution shown | $96.15 | 19.0% | 2 | 2025 |
| UCB, Inc. | Unresolved — no canonical attribution shown | $71.37 | 14.1% | 4 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $49.64 | 9.8% | 2 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $39.66 | 7.8% | 2 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $39.29 | 7.8% | 2 | 2025 |
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $32.10 | 6.3% | 1 | 2025 |
| E.R. Squibb & Sons, L.L.C. | Unresolved — no canonical attribution shown | $13.47 | 2.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $506.16 | 30 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Motpoly XR Normalized: motpoly xr |
Drug | Aucta Pharmaceuticals, Inc. | $164.48 | 16 | 2025 |
Source payment records
|
|||||
| Zunveyl Normalized: zunveyl |
Drug | Alpha Cognition USA, Inc. | $96.15 | 2 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka America Pharmaceutical, Inc. | $88.93 | 4 | 2025 |
Source payment records
|
|||||
| Nayzilam Normalized: nayzilam |
Drug | UCB, Inc. | $55.22 | 3 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $39.66 | 2 | 2025 |
Source payment records
|
|||||
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $32.10 | 1 | 2025 |
Source payment records
|
|||||
| Briviact Normalized: briviact |
Drug | UCB, Inc. | $16.15 | 1 | 2025 |
Source payment records
|
|||||
| COBENFY Normalized: cobenfy |
Drug | E.R. Squibb & Sons, L.L.C. | $13.47 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 112 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
734 | 72 |
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
112 | 16 |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
40 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1472 | 242 |
| Amlodipine Besylate | Amlodipine Besylate | 1010 | 159 |
| Furosemide | Furosemide | 935 | 131 |
| Gabapentin | Gabapentin | 785 | 139 |
| Eliquis | Apixaban | 734 | 72 |
| Divalproex Sodium | Divalproex Sodium | 670 | 104 |
| Levothyroxine Sodium | Levothyroxine Sodium | 642 | 88 |
| Lisinopril | Lisinopril | 639 | 99 |
| Trazodone Hcl | Trazodone Hcl | 616 | 110 |
| Gemtesa | Vibegron | 603 | 36 |
| Metformin Hcl | Metformin Hcl | 557 | 79 |
| Potassium Chloride | Potassium Chloride | 511 | 85 |
| Carvedilol | Carvedilol | 484 | 82 |
| Sertraline Hcl | Sertraline Hcl | 467 | 84 |
| Metoprolol Tartrate | Metoprolol Tartrate | 459 | 81 |
| Mirtazapine | Mirtazapine | 436 | 85 |
| Tamsulosin Hcl | Tamsulosin Hcl | 430 | 76 |
| Memantine Hcl | Memantine Hcl | 400 | 64 |
| Enulose | Lactulose | 396 | 47 |
| Risperidone | Risperidone | 387 | 62 |
| Donepezil Hcl | Donepezil Hcl | 363 | 62 |
| Levetiracetam | Levetiracetam | 339 | 48 |
| Simvastatin | Simvastatin | 336 | 39 |
| Buspirone Hcl | Buspirone Hcl | 325 | 70 |
| Quetiapine Fumarate | Quetiapine Fumarate | 320 | 52 |
| Latanoprost | Latanoprost | 319 | 45 |
| Omeprazole | Omeprazole | 312 | 63 |
| Hydralazine Hcl | Hydralazine Hcl | 310 | 59 |
| Clopidogrel | Clopidogrel Bisulfate | 308 | 53 |
| Pantoprazole Sodium | Pantoprazole Sodium | 303 | 67 |
| Spironolactone | Spironolactone | 293 | 43 |
| Losartan Potassium | Losartan Potassium | 272 | 57 |
| Metoprolol Succinate | Metoprolol Succinate | 257 | 52 |
| Famotidine | Famotidine | 252 | 47 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 244 | 39 |
| Olanzapine | Olanzapine | 240 | 40 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 223 | 35 |
| Escitalopram Oxalate | Escitalopram Oxalate | 209 | 40 |
| Duloxetine Hcl | Duloxetine Hcl | 207 | 43 |
| Tramadol Hcl | Tramadol Hcl | 206 | 48 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 196 | 50 |
| Oxcarbazepine | Oxcarbazepine | 192 | 31 |
| Benztropine Mesylate | Benztropine Mesylate | 173 | 22 |
| Xarelto | Rivaroxaban | 165 | 13 |
| Lorazepam | Lorazepam | 160 | 46 |
| Jardiance | Empagliflozin | 145 | 19 |
| Januvia | Sitagliptin Phosphate | 140 | 14 |
| Glipizide | Glipizide | 135 | 23 |
| Nifedipine Er | Nifedipine | 135 | 23 |
| Baclofen | Baclofen | 131 | 27 |
| Montelukast Sodium | Montelukast Sodium | 131 | 24 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 131 | 21 |
| Austedo Xr | Deutetrabenazine | 127 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 122 | 13 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 121 | 57 |
| Finasteride | Finasteride | 120 | 21 |
| Clonidine Hcl | Clonidine Hcl | 117 | 30 |
| Fluticasone Propionate | Fluticasone Propionate | 115 | 37 |
| Ondansetron Hcl | Ondansetron Hcl | 115 | 53 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 113 | 19 |
| Ezetimibe | Ezetimibe | 113 | 12 |
| Ingrezza | Valbenazine Tosylate | 112 | 16 |
| Clonazepam | Clonazepam | 111 | 17 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 108 | suppressed |
| Myrbetriq | Mirabegron | 103 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 101 | 36 |
| Humalog Kwikpen U-100 | Insulin Lispro | 97 | 19 |
| Tradjenta | Linagliptin | 97 | suppressed |
| Sucralfate | Sucralfate | 94 | 20 |
| Divalproex Sodium Er | Divalproex Sodium | 93 | 18 |
| Linzess | Linaclotide | 93 | suppressed |
| Haloperidol | Haloperidol | 88 | 12 |
| Methocarbamol | Methocarbamol | 88 | 28 |
| Budesonide | Budesonide | 87 | 15 |
| Midodrine Hcl | Midodrine Hcl | 84 | 24 |
| Propranolol Hcl | Propranolol Hcl | 82 | 14 |
| Brimonidine Tartrate | Brimonidine Tartrate | 81 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 81 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 80 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 78 | 26 |
| Entresto | Sacubitril/Valsartan | 78 | suppressed |
| Levemir Flexpen | Insulin Detemir | 77 | 20 |
| Aripiprazole | Aripiprazole | 75 | 17 |
| Metformin Hcl Er | Metformin Hcl | 74 | suppressed |
| Allopurinol | Allopurinol | 72 | 14 |
| Aptiom | Eslicarbazepine Acetate | 72 | suppressed |
| Levofloxacin | Levofloxacin | 71 | 38 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 71 | suppressed |
| Amoxicillin | Amoxicillin | 70 | 46 |
| Ibuprofen | Ibuprofen | 70 | 36 |
| Amiodarone Hcl | Amiodarone Hcl | 69 | 16 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 68 | 47 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 67 | 34 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 66 | 12 |
| Fenofibrate | Fenofibrate,micronized | 63 | suppressed |
| Atenolol | Atenolol | 61 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 61 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 61 | 43 |
| Diclofenac Sodium | Diclofenac Sodium | 59 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 58 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 58 | 14 |
| Lamotrigine | Lamotrigine | 56 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 56 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 55 | 35 |
| Glipizide Er | Glipizide | 55 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 54 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 54 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 53 | 13 |
| Invega Sustenna | Paliperidone Palmitate | 53 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 53 | 17 |
| Lithium Carbonate | Lithium Carbonate | 50 | suppressed |
| Xifaxan | Rifaximin | 50 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 49 | 35 |
| Farxiga | Dapagliflozin Propanediol | 49 | suppressed |
| Scopolamine | Scopolamine | 49 | suppressed |
| Metronidazole | Metronidazole | 48 | 14 |
| Clozapine | Clozapine | 47 | suppressed |
| Nystatin | Nystatin | 47 | 24 |
| Bumetanide | Bumetanide | 46 | 11 |
| Prednisone | Prednisone | 46 | 24 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 46 | 33 |
| Topiramate | Topiramate | 45 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 44 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 44 | suppressed |
| Alprazolam | Alprazolam | 43 | suppressed |
| Timolol Maleate | Timolol Maleate | 43 | suppressed |
| Cephalexin | Cephalexin | 42 | 22 |
| Doxazosin Mesylate | Doxazosin Mesylate | 42 | suppressed |
| Torsemide | Torsemide | 42 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 41 | 11 |
| Pentoxifylline | Pentoxifylline | 41 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 40 | suppressed |
| Calcium Acetate | Calcium Acetate | 39 | suppressed |
| Rivastigmine | Rivastigmine | 39 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 39 | 11 |
| Albuterol Sulfate | Albuterol Sulfate | 38 | 29 |
| Ropinirole Hcl | Ropinirole Hcl | 38 | suppressed |
| Carbamazepine Er | Carbamazepine | 37 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 37 | 15 |
| Dorzolamide Hcl | Dorzolamide Hcl | 37 | suppressed |
| Lacosamide | Lacosamide | 37 | suppressed |
| Nyamyc | Nystatin | 37 | 19 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 36 | suppressed |
| Gemfibrozil | Gemfibrozil | 36 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 36 | 19 |
| Prazosin Hcl | Prazosin Hcl | 35 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 35 | 21 |
| Amantadine | Amantadine Hcl | 34 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 34 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 32 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 32 | 11 |
| Nystop | Nystatin | 32 | 13 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 32 | 13 |
| Calcitriol | Calcitriol | 31 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 31 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 31 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 30 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 30 | 18 |
| Lidocaine | Lidocaine | 30 | suppressed |
| Phenytoin | Phenytoin | 30 | suppressed |
| Anastrozole | Anastrozole | 29 | suppressed |
| Lactulose | Lactulose | 29 | 13 |
| Methimazole | Methimazole | 29 | suppressed |
| Carbamazepine | Carbamazepine | 28 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 28 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 28 | suppressed |
| Bupropion Xl | Bupropion Hcl | 27 | suppressed |
| Meloxicam | Meloxicam | 27 | suppressed |
| Perphenazine | Perphenazine | 27 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 25 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 25 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 25 | suppressed |
| Phenytek | Phenytoin Sodium Extended | 25 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 25 | suppressed |
| Nitroglycerin | Nitroglycerin | 24 | 19 |
| Novolog Flexpen | Insulin Aspart | 24 | suppressed |
| Pregabalin | Pregabalin | 24 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 24 | 15 |
| Terazosin Hcl | Terazosin Hcl | 24 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 24 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 23 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 23 | suppressed |
| Hydrocortisone | Hydrocortisone | 23 | 13 |
| Imatinib Mesylate | Imatinib Mesylate | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 23 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 23 | suppressed |
| Premarin | Estrogens, Conjugated | 23 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 23 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 22 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 22 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 22 | 14 |
| Humalog | Insulin Lispro | 22 | suppressed |
| Klayesta | Nystatin | 22 | 15 |
| Brilinta | Ticagrelor | 21 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 21 | suppressed |
| Fenofibrate | Fenofibrate | 21 | suppressed |
| Phenobarbital | Phenobarbital | 21 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 21 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 20 | suppressed |
| Nifedipine | Nifedipine | 20 | suppressed |
| Novolog | Insulin Aspart | 20 | suppressed |
| Restasis | Cyclosporine | 20 | suppressed |
| Vraylar | Cariprazine Hcl | 20 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 20 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 19 | suppressed |
| Cefdinir | Cefdinir | 19 | 16 |
| Diazepam | Diazepam | 19 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 19 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 19 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 18 | suppressed |
| Dexamethasone | Dexamethasone | 18 | 18 |
| Ondansetron Odt | Ondansetron | 18 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 18 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 17 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 17 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 17 | suppressed |
| Mupirocin | Mupirocin | 17 | suppressed |
| Azithromycin | Azithromycin | 16 | 12 |
| Clonidine | Clonidine | 16 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | 11 |
| Labetalol Hcl | Labetalol Hcl | 16 | suppressed |
| Loperamide | Loperamide Hcl | 16 | suppressed |
| Naproxen | Naproxen | 16 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 16 | suppressed |
| Prezcobix | Darunavir/Cobicistat | 16 | suppressed |
| Ranolazine Er | Ranolazine | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 15 | suppressed |
| Caplyta | Lumateperone Tosylate | 14 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Leflunomide | Leflunomide | 14 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 14 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 13 | suppressed |
| Insulin Lispro Protamine Mix | Insulin Lispro Protamin/Lispro | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Olanzapine Odt | Olanzapine | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Reclipsen | Desogestrel-Ethinyl Estradiol | 13 | suppressed |
| Trifluoperazine Hcl | Trifluoperazine Hcl | 13 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 12 | suppressed |
| Levemir | Insulin Detemir | 12 | suppressed |
| Paroxetine Cr | Paroxetine Hcl | 12 | suppressed |
| Renvela | Sevelamer Carbonate | 12 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 12 | suppressed |
| Azathioprine | Azathioprine | 11 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 11 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 11 | suppressed |
| Enbrel Sureclick | Etanercept | 11 | suppressed |
| Fluphenazine Decanoate | Fluphenazine Decanoate | 11 | suppressed |
| Glimepiride | Glimepiride | 11 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 11 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 11 | suppressed |
| Risperidone Er | Risperidone Microspheres | 11 | suppressed |
| Tivicay | Dolutegravir Sodium | 11 | suppressed |
| Valproic Acid | Valproic Acid | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $506.16 · 30 records | Aucta Pharmaceuticals, Inc. | Briviact, COBENFY, FANAPT, INGREZZA, Motpoly XR, Nayzilam, REXULTI, Zunveyl | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ingrezza play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with E.R. Squibb & Sons, L.L.C.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error